nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—epilepsy syndrome	0.131	1	CbGaD
Alitretinoin—ABCB1—Levetiracetam—epilepsy syndrome	0.042	0.125	CbGbCtD
Alitretinoin—ABCB1—Clobazam—epilepsy syndrome	0.0291	0.0863	CbGbCtD
Alitretinoin—ABCB1—Lamotrigine—epilepsy syndrome	0.028	0.0831	CbGbCtD
Alitretinoin—CYP1A2—Carbamazepine—epilepsy syndrome	0.0276	0.0818	CbGbCtD
Alitretinoin—CYP1A2—Primidone—epilepsy syndrome	0.0258	0.0763	CbGbCtD
Alitretinoin—ABCB1—Carbamazepine—epilepsy syndrome	0.0241	0.0715	CbGbCtD
Alitretinoin—CYP1A2—Propofol—epilepsy syndrome	0.0231	0.0684	CbGbCtD
Alitretinoin—CYP1A2—Phenobarbital—epilepsy syndrome	0.0221	0.0654	CbGbCtD
Alitretinoin—ABCB1—Phenytoin—epilepsy syndrome	0.0217	0.0641	CbGbCtD
Alitretinoin—CYP1A2—Diazepam—epilepsy syndrome	0.0209	0.062	CbGbCtD
Alitretinoin—ABCB1—Phenobarbital—epilepsy syndrome	0.0193	0.0572	CbGbCtD
Alitretinoin—ABCB1—Midazolam—epilepsy syndrome	0.019	0.0564	CbGbCtD
Alitretinoin—ABCB1—Diazepam—epilepsy syndrome	0.0183	0.0542	CbGbCtD
Alitretinoin—CYP1A2—Valproic Acid—epilepsy syndrome	0.0165	0.0489	CbGbCtD
Alitretinoin—RXRA—ganglion—epilepsy syndrome	0.00547	0.0696	CbGeAlD
Alitretinoin—CRABP1—hindbrain—epilepsy syndrome	0.00461	0.0587	CbGeAlD
Alitretinoin—RARG—tongue—epilepsy syndrome	0.00397	0.0505	CbGeAlD
Alitretinoin—CRABP1—brainstem—epilepsy syndrome	0.00264	0.0336	CbGeAlD
Alitretinoin—CRABP2—forebrain—epilepsy syndrome	0.00231	0.0293	CbGeAlD
Alitretinoin—RXRA—forebrain—epilepsy syndrome	0.00229	0.0292	CbGeAlD
Alitretinoin—RXRA—telencephalon—epilepsy syndrome	0.00211	0.0269	CbGeAlD
Alitretinoin—CRABP1—medulla oblongata—epilepsy syndrome	0.00184	0.0234	CbGeAlD
Alitretinoin—RXRB—telencephalon—epilepsy syndrome	0.00174	0.0222	CbGeAlD
Alitretinoin—CRABP1—midbrain—epilepsy syndrome	0.00168	0.0214	CbGeAlD
Alitretinoin—CRABP2—medulla oblongata—epilepsy syndrome	0.00167	0.0212	CbGeAlD
Alitretinoin—CRABP1—spinal cord—epilepsy syndrome	0.00164	0.0209	CbGeAlD
Alitretinoin—CRABP2—spinal cord—epilepsy syndrome	0.00149	0.0189	CbGeAlD
Alitretinoin—CRABP1—head—epilepsy syndrome	0.00146	0.0186	CbGeAlD
Alitretinoin—RXRG—medulla oblongata—epilepsy syndrome	0.00146	0.0185	CbGeAlD
Alitretinoin—RARA—telencephalon—epilepsy syndrome	0.00145	0.0185	CbGeAlD
Alitretinoin—CRABP1—nervous system—epilepsy syndrome	0.00138	0.0176	CbGeAlD
Alitretinoin—CRABP1—central nervous system—epilepsy syndrome	0.00133	0.017	CbGeAlD
Alitretinoin—RXRG—midbrain—epilepsy syndrome	0.00133	0.0169	CbGeAlD
Alitretinoin—CRABP2—head—epilepsy syndrome	0.00132	0.0168	CbGeAlD
Alitretinoin—RXRA—head—epilepsy syndrome	0.00131	0.0167	CbGeAlD
Alitretinoin—CRABP1—cerebellum—epilepsy syndrome	0.0013	0.0166	CbGeAlD
Alitretinoin—RXRG—spinal cord—epilepsy syndrome	0.0013	0.0165	CbGeAlD
Alitretinoin—CRABP2—nervous system—epilepsy syndrome	0.00125	0.0159	CbGeAlD
Alitretinoin—RXRA—nervous system—epilepsy syndrome	0.00125	0.0159	CbGeAlD
Alitretinoin—CRABP2—central nervous system—epilepsy syndrome	0.0012	0.0153	CbGeAlD
Alitretinoin—RXRA—central nervous system—epilepsy syndrome	0.0012	0.0153	CbGeAlD
Alitretinoin—RARB—head—epilepsy syndrome	0.00118	0.015	CbGeAlD
Alitretinoin—CRABP2—cerebellum—epilepsy syndrome	0.00118	0.015	CbGeAlD
Alitretinoin—RXRG—head—epilepsy syndrome	0.00115	0.0147	CbGeAlD
Alitretinoin—RXRG—nervous system—epilepsy syndrome	0.00109	0.0139	CbGeAlD
Alitretinoin—RXRB—head—epilepsy syndrome	0.00108	0.0138	CbGeAlD
Alitretinoin—CRABP1—brain—epilepsy syndrome	0.00106	0.0135	CbGeAlD
Alitretinoin—RARB—cerebellum—epilepsy syndrome	0.00105	0.0134	CbGeAlD
Alitretinoin—RXRG—central nervous system—epilepsy syndrome	0.00105	0.0134	CbGeAlD
Alitretinoin—RXRB—nervous system—epilepsy syndrome	0.00103	0.0131	CbGeAlD
Alitretinoin—RXRB—central nervous system—epilepsy syndrome	0.00099	0.0126	CbGeAlD
Alitretinoin—RXRB—cerebellum—epilepsy syndrome	0.000968	0.0123	CbGeAlD
Alitretinoin—RARG—head—epilepsy syndrome	0.000963	0.0123	CbGeAlD
Alitretinoin—CRABP2—brain—epilepsy syndrome	0.000956	0.0122	CbGeAlD
Alitretinoin—RXRA—brain—epilepsy syndrome	0.000952	0.0121	CbGeAlD
Alitretinoin—RARG—nervous system—epilepsy syndrome	0.000913	0.0116	CbGeAlD
Alitretinoin—RARA—head—epilepsy syndrome	0.000905	0.0115	CbGeAlD
Alitretinoin—RARG—central nervous system—epilepsy syndrome	0.000879	0.0112	CbGeAlD
Alitretinoin—RARG—cerebellum—epilepsy syndrome	0.000859	0.0109	CbGeAlD
Alitretinoin—RARA—nervous system—epilepsy syndrome	0.000858	0.0109	CbGeAlD
Alitretinoin—RARB—brain—epilepsy syndrome	0.000855	0.0109	CbGeAlD
Alitretinoin—RXRG—brain—epilepsy syndrome	0.000836	0.0106	CbGeAlD
Alitretinoin—RARA—central nervous system—epilepsy syndrome	0.000826	0.0105	CbGeAlD
Alitretinoin—RARA—cerebellum—epilepsy syndrome	0.000808	0.0103	CbGeAlD
Alitretinoin—RXRB—brain—epilepsy syndrome	0.000786	0.01	CbGeAlD
Alitretinoin—RARG—brain—epilepsy syndrome	0.000698	0.00888	CbGeAlD
Alitretinoin—RARA—brain—epilepsy syndrome	0.000656	0.00835	CbGeAlD
Alitretinoin—ABCB1—forebrain—epilepsy syndrome	0.0003	0.00382	CbGeAlD
Alitretinoin—ABCB1—telencephalon—epilepsy syndrome	0.000276	0.00352	CbGeAlD
Alitretinoin—ABCB1—medulla oblongata—epilepsy syndrome	0.000217	0.00276	CbGeAlD
Alitretinoin—ABCB1—midbrain—epilepsy syndrome	0.000198	0.00252	CbGeAlD
Alitretinoin—ABCB1—spinal cord—epilepsy syndrome	0.000193	0.00246	CbGeAlD
Alitretinoin—ABCB1—head—epilepsy syndrome	0.000172	0.00219	CbGeAlD
Alitretinoin—ABCB1—nervous system—epilepsy syndrome	0.000163	0.00208	CbGeAlD
Alitretinoin—ABCB1—central nervous system—epilepsy syndrome	0.000157	0.002	CbGeAlD
Alitretinoin—ABCB1—cerebellum—epilepsy syndrome	0.000153	0.00195	CbGeAlD
Alitretinoin—ABCB1—brain—epilepsy syndrome	0.000125	0.00159	CbGeAlD
Alitretinoin—Chest pain—Pregabalin—epilepsy syndrome	3.9e-05	0.000116	CcSEcCtD
Alitretinoin—Myalgia—Pregabalin—epilepsy syndrome	3.9e-05	0.000116	CcSEcCtD
Alitretinoin—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.89e-05	0.000116	CcSEcCtD
Alitretinoin—Dizziness—Zonisamide—epilepsy syndrome	3.89e-05	0.000116	CcSEcCtD
Alitretinoin—Headache—Diazepam—epilepsy syndrome	3.89e-05	0.000116	CcSEcCtD
Alitretinoin—Anxiety—Pregabalin—epilepsy syndrome	3.88e-05	0.000115	CcSEcCtD
Alitretinoin—Diarrhoea—Clonazepam—epilepsy syndrome	3.88e-05	0.000115	CcSEcCtD
Alitretinoin—Anaemia—Gabapentin—epilepsy syndrome	3.88e-05	0.000115	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.87e-05	0.000115	CcSEcCtD
Alitretinoin—Hypotension—Valproic Acid—epilepsy syndrome	3.86e-05	0.000115	CcSEcCtD
Alitretinoin—Asthenia—Carbamazepine—epilepsy syndrome	3.86e-05	0.000115	CcSEcCtD
Alitretinoin—Agitation—Gabapentin—epilepsy syndrome	3.86e-05	0.000115	CcSEcCtD
Alitretinoin—Diarrhoea—Phenytoin—epilepsy syndrome	3.86e-05	0.000115	CcSEcCtD
Alitretinoin—Discomfort—Pregabalin—epilepsy syndrome	3.85e-05	0.000114	CcSEcCtD
Alitretinoin—Nausea—Fosphenytoin—epilepsy syndrome	3.85e-05	0.000114	CcSEcCtD
Alitretinoin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.84e-05	0.000114	CcSEcCtD
Alitretinoin—Erythema multiforme—Topiramate—epilepsy syndrome	3.83e-05	0.000114	CcSEcCtD
Alitretinoin—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.83e-05	0.000114	CcSEcCtD
Alitretinoin—Vomiting—Felbamate—epilepsy syndrome	3.82e-05	0.000114	CcSEcCtD
Alitretinoin—Dry mouth—Pregabalin—epilepsy syndrome	3.81e-05	0.000113	CcSEcCtD
Alitretinoin—Pruritus—Carbamazepine—epilepsy syndrome	3.81e-05	0.000113	CcSEcCtD
Alitretinoin—Rash—Felbamate—epilepsy syndrome	3.79e-05	0.000113	CcSEcCtD
Alitretinoin—Eye disorder—Topiramate—epilepsy syndrome	3.79e-05	0.000113	CcSEcCtD
Alitretinoin—Dermatitis—Felbamate—epilepsy syndrome	3.79e-05	0.000113	CcSEcCtD
Alitretinoin—Malaise—Gabapentin—epilepsy syndrome	3.78e-05	0.000112	CcSEcCtD
Alitretinoin—Tinnitus—Topiramate—epilepsy syndrome	3.78e-05	0.000112	CcSEcCtD
Alitretinoin—Headache—Felbamate—epilepsy syndrome	3.77e-05	0.000112	CcSEcCtD
Alitretinoin—Confusional state—Pregabalin—epilepsy syndrome	3.77e-05	0.000112	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.76e-05	0.000112	CcSEcCtD
Alitretinoin—Flushing—Topiramate—epilepsy syndrome	3.76e-05	0.000112	CcSEcCtD
Alitretinoin—Syncope—Gabapentin—epilepsy syndrome	3.76e-05	0.000112	CcSEcCtD
Alitretinoin—Dizziness—Clonazepam—epilepsy syndrome	3.75e-05	0.000111	CcSEcCtD
Alitretinoin—Nausea—Vigabatrin—epilepsy syndrome	3.75e-05	0.000111	CcSEcCtD
Alitretinoin—Vomiting—Zonisamide—epilepsy syndrome	3.74e-05	0.000111	CcSEcCtD
Alitretinoin—Insomnia—Valproic Acid—epilepsy syndrome	3.74e-05	0.000111	CcSEcCtD
Alitretinoin—Oedema—Pregabalin—epilepsy syndrome	3.73e-05	0.000111	CcSEcCtD
Alitretinoin—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.73e-05	0.000111	CcSEcCtD
Alitretinoin—Asthenia—Lamotrigine—epilepsy syndrome	3.73e-05	0.000111	CcSEcCtD
Alitretinoin—Dizziness—Phenytoin—epilepsy syndrome	3.73e-05	0.000111	CcSEcCtD
Alitretinoin—Rash—Zonisamide—epilepsy syndrome	3.71e-05	0.00011	CcSEcCtD
Alitretinoin—Infection—Pregabalin—epilepsy syndrome	3.71e-05	0.00011	CcSEcCtD
Alitretinoin—Paraesthesia—Valproic Acid—epilepsy syndrome	3.71e-05	0.00011	CcSEcCtD
Alitretinoin—Palpitations—Gabapentin—epilepsy syndrome	3.71e-05	0.00011	CcSEcCtD
Alitretinoin—Dermatitis—Zonisamide—epilepsy syndrome	3.71e-05	0.00011	CcSEcCtD
Alitretinoin—Dizziness—Oxcarbazepine—epilepsy syndrome	3.71e-05	0.00011	CcSEcCtD
Alitretinoin—Nausea—Diazepam—epilepsy syndrome	3.69e-05	0.00011	CcSEcCtD
Alitretinoin—Loss of consciousness—Gabapentin—epilepsy syndrome	3.69e-05	0.00011	CcSEcCtD
Alitretinoin—Headache—Zonisamide—epilepsy syndrome	3.69e-05	0.00011	CcSEcCtD
Alitretinoin—Dyspnoea—Valproic Acid—epilepsy syndrome	3.68e-05	0.000109	CcSEcCtD
Alitretinoin—Diarrhoea—Carbamazepine—epilepsy syndrome	3.68e-05	0.000109	CcSEcCtD
Alitretinoin—Angiopathy—Topiramate—epilepsy syndrome	3.68e-05	0.000109	CcSEcCtD
Alitretinoin—Pruritus—Lamotrigine—epilepsy syndrome	3.68e-05	0.000109	CcSEcCtD
Alitretinoin—Shock—Pregabalin—epilepsy syndrome	3.67e-05	0.000109	CcSEcCtD
Alitretinoin—Somnolence—Valproic Acid—epilepsy syndrome	3.67e-05	0.000109	CcSEcCtD
Alitretinoin—Nervous system disorder—Pregabalin—epilepsy syndrome	3.66e-05	0.000109	CcSEcCtD
Alitretinoin—Cough—Gabapentin—epilepsy syndrome	3.66e-05	0.000109	CcSEcCtD
Alitretinoin—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.66e-05	0.000109	CcSEcCtD
Alitretinoin—Tachycardia—Pregabalin—epilepsy syndrome	3.65e-05	0.000108	CcSEcCtD
Alitretinoin—Chills—Topiramate—epilepsy syndrome	3.64e-05	0.000108	CcSEcCtD
Alitretinoin—Dyspepsia—Valproic Acid—epilepsy syndrome	3.64e-05	0.000108	CcSEcCtD
Alitretinoin—Convulsion—Gabapentin—epilepsy syndrome	3.64e-05	0.000108	CcSEcCtD
Alitretinoin—Skin disorder—Pregabalin—epilepsy syndrome	3.63e-05	0.000108	CcSEcCtD
Alitretinoin—Hypertension—Gabapentin—epilepsy syndrome	3.62e-05	0.000108	CcSEcCtD
Alitretinoin—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.61e-05	0.000107	CcSEcCtD
Alitretinoin—Vomiting—Clonazepam—epilepsy syndrome	3.61e-05	0.000107	CcSEcCtD
Alitretinoin—Decreased appetite—Valproic Acid—epilepsy syndrome	3.59e-05	0.000107	CcSEcCtD
Alitretinoin—Alopecia—Topiramate—epilepsy syndrome	3.58e-05	0.000106	CcSEcCtD
Alitretinoin—Vomiting—Phenytoin—epilepsy syndrome	3.58e-05	0.000106	CcSEcCtD
Alitretinoin—Rash—Clonazepam—epilepsy syndrome	3.58e-05	0.000106	CcSEcCtD
Alitretinoin—Dermatitis—Clonazepam—epilepsy syndrome	3.57e-05	0.000106	CcSEcCtD
Alitretinoin—Myalgia—Gabapentin—epilepsy syndrome	3.57e-05	0.000106	CcSEcCtD
Alitretinoin—Arthralgia—Gabapentin—epilepsy syndrome	3.57e-05	0.000106	CcSEcCtD
Alitretinoin—Chest pain—Gabapentin—epilepsy syndrome	3.57e-05	0.000106	CcSEcCtD
Alitretinoin—Nausea—Felbamate—epilepsy syndrome	3.57e-05	0.000106	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.57e-05	0.000106	CcSEcCtD
Alitretinoin—Vomiting—Oxcarbazepine—epilepsy syndrome	3.56e-05	0.000106	CcSEcCtD
Alitretinoin—Fatigue—Valproic Acid—epilepsy syndrome	3.56e-05	0.000106	CcSEcCtD
Alitretinoin—Anxiety—Gabapentin—epilepsy syndrome	3.56e-05	0.000106	CcSEcCtD
Alitretinoin—Anorexia—Pregabalin—epilepsy syndrome	3.56e-05	0.000106	CcSEcCtD
Alitretinoin—Dizziness—Carbamazepine—epilepsy syndrome	3.56e-05	0.000106	CcSEcCtD
Alitretinoin—Diarrhoea—Lamotrigine—epilepsy syndrome	3.56e-05	0.000106	CcSEcCtD
Alitretinoin—Headache—Clonazepam—epilepsy syndrome	3.55e-05	0.000106	CcSEcCtD
Alitretinoin—Rash—Phenytoin—epilepsy syndrome	3.55e-05	0.000106	CcSEcCtD
Alitretinoin—Mental disorder—Topiramate—epilepsy syndrome	3.55e-05	0.000106	CcSEcCtD
Alitretinoin—Dermatitis—Phenytoin—epilepsy syndrome	3.55e-05	0.000105	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.55e-05	0.000105	CcSEcCtD
Alitretinoin—Rash—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.000105	CcSEcCtD
Alitretinoin—Pain—Valproic Acid—epilepsy syndrome	3.53e-05	0.000105	CcSEcCtD
Alitretinoin—Constipation—Valproic Acid—epilepsy syndrome	3.53e-05	0.000105	CcSEcCtD
Alitretinoin—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.000105	CcSEcCtD
Alitretinoin—Headache—Phenytoin—epilepsy syndrome	3.53e-05	0.000105	CcSEcCtD
Alitretinoin—Malnutrition—Topiramate—epilepsy syndrome	3.53e-05	0.000105	CcSEcCtD
Alitretinoin—Erythema—Topiramate—epilepsy syndrome	3.53e-05	0.000105	CcSEcCtD
Alitretinoin—Discomfort—Gabapentin—epilepsy syndrome	3.53e-05	0.000105	CcSEcCtD
Alitretinoin—Headache—Oxcarbazepine—epilepsy syndrome	3.51e-05	0.000104	CcSEcCtD
Alitretinoin—Nausea—Zonisamide—epilepsy syndrome	3.5e-05	0.000104	CcSEcCtD
Alitretinoin—Dry mouth—Gabapentin—epilepsy syndrome	3.49e-05	0.000104	CcSEcCtD
Alitretinoin—Hypotension—Pregabalin—epilepsy syndrome	3.49e-05	0.000104	CcSEcCtD
Alitretinoin—Flatulence—Topiramate—epilepsy syndrome	3.48e-05	0.000103	CcSEcCtD
Alitretinoin—Tension—Topiramate—epilepsy syndrome	3.46e-05	0.000103	CcSEcCtD
Alitretinoin—Confusional state—Gabapentin—epilepsy syndrome	3.45e-05	0.000103	CcSEcCtD
Alitretinoin—Dizziness—Lamotrigine—epilepsy syndrome	3.44e-05	0.000102	CcSEcCtD
Alitretinoin—Nervousness—Topiramate—epilepsy syndrome	3.43e-05	0.000102	CcSEcCtD
Alitretinoin—Oedema—Gabapentin—epilepsy syndrome	3.42e-05	0.000102	CcSEcCtD
Alitretinoin—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.42e-05	0.000102	CcSEcCtD
Alitretinoin—Vomiting—Carbamazepine—epilepsy syndrome	3.42e-05	0.000102	CcSEcCtD
Alitretinoin—Back pain—Topiramate—epilepsy syndrome	3.42e-05	0.000101	CcSEcCtD
Alitretinoin—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.4e-05	0.000101	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.4e-05	0.000101	CcSEcCtD
Alitretinoin—Infection—Gabapentin—epilepsy syndrome	3.4e-05	0.000101	CcSEcCtD
Alitretinoin—Rash—Carbamazepine—epilepsy syndrome	3.39e-05	0.000101	CcSEcCtD
Alitretinoin—Dermatitis—Carbamazepine—epilepsy syndrome	3.39e-05	0.000101	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.38e-05	0.0001	CcSEcCtD
Alitretinoin—Insomnia—Pregabalin—epilepsy syndrome	3.38e-05	0.0001	CcSEcCtD
Alitretinoin—Nausea—Clonazepam—epilepsy syndrome	3.37e-05	0.0001	CcSEcCtD
Alitretinoin—Headache—Carbamazepine—epilepsy syndrome	3.37e-05	0.0001	CcSEcCtD
Alitretinoin—Shock—Gabapentin—epilepsy syndrome	3.37e-05	0.0001	CcSEcCtD
Alitretinoin—Nervous system disorder—Gabapentin—epilepsy syndrome	3.36e-05	9.98e-05	CcSEcCtD
Alitretinoin—Paraesthesia—Pregabalin—epilepsy syndrome	3.35e-05	9.96e-05	CcSEcCtD
Alitretinoin—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.35e-05	9.96e-05	CcSEcCtD
Alitretinoin—Nausea—Phenytoin—epilepsy syndrome	3.35e-05	9.94e-05	CcSEcCtD
Alitretinoin—Tachycardia—Gabapentin—epilepsy syndrome	3.34e-05	9.93e-05	CcSEcCtD
Alitretinoin—Dyspnoea—Pregabalin—epilepsy syndrome	3.33e-05	9.89e-05	CcSEcCtD
Alitretinoin—Nausea—Oxcarbazepine—epilepsy syndrome	3.33e-05	9.89e-05	CcSEcCtD
Alitretinoin—Vision blurred—Topiramate—epilepsy syndrome	3.33e-05	9.88e-05	CcSEcCtD
Alitretinoin—Skin disorder—Gabapentin—epilepsy syndrome	3.33e-05	9.88e-05	CcSEcCtD
Alitretinoin—Somnolence—Pregabalin—epilepsy syndrome	3.32e-05	9.86e-05	CcSEcCtD
Alitretinoin—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.31e-05	9.83e-05	CcSEcCtD
Alitretinoin—Tremor—Topiramate—epilepsy syndrome	3.31e-05	9.82e-05	CcSEcCtD
Alitretinoin—Vomiting—Lamotrigine—epilepsy syndrome	3.31e-05	9.82e-05	CcSEcCtD
Alitretinoin—Urticaria—Valproic Acid—epilepsy syndrome	3.28e-05	9.75e-05	CcSEcCtD
Alitretinoin—Rash—Lamotrigine—epilepsy syndrome	3.28e-05	9.74e-05	CcSEcCtD
Alitretinoin—Ill-defined disorder—Topiramate—epilepsy syndrome	3.28e-05	9.73e-05	CcSEcCtD
Alitretinoin—Dermatitis—Lamotrigine—epilepsy syndrome	3.28e-05	9.73e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Valproic Acid—epilepsy syndrome	3.27e-05	9.7e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Valproic Acid—epilepsy syndrome	3.27e-05	9.7e-05	CcSEcCtD
Alitretinoin—Anorexia—Gabapentin—epilepsy syndrome	3.26e-05	9.7e-05	CcSEcCtD
Alitretinoin—Anaemia—Topiramate—epilepsy syndrome	3.26e-05	9.69e-05	CcSEcCtD
Alitretinoin—Headache—Lamotrigine—epilepsy syndrome	3.26e-05	9.67e-05	CcSEcCtD
Alitretinoin—Decreased appetite—Pregabalin—epilepsy syndrome	3.25e-05	9.64e-05	CcSEcCtD
Alitretinoin—Agitation—Topiramate—epilepsy syndrome	3.24e-05	9.64e-05	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.22e-05	9.58e-05	CcSEcCtD
Alitretinoin—Fatigue—Pregabalin—epilepsy syndrome	3.22e-05	9.56e-05	CcSEcCtD
Alitretinoin—Hypotension—Gabapentin—epilepsy syndrome	3.2e-05	9.51e-05	CcSEcCtD
Alitretinoin—Nausea—Carbamazepine—epilepsy syndrome	3.2e-05	9.49e-05	CcSEcCtD
Alitretinoin—Constipation—Pregabalin—epilepsy syndrome	3.19e-05	9.49e-05	CcSEcCtD
Alitretinoin—Pain—Pregabalin—epilepsy syndrome	3.19e-05	9.49e-05	CcSEcCtD
Alitretinoin—Malaise—Topiramate—epilepsy syndrome	3.18e-05	9.46e-05	CcSEcCtD
Alitretinoin—Syncope—Topiramate—epilepsy syndrome	3.17e-05	9.4e-05	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.12e-05	9.27e-05	CcSEcCtD
Alitretinoin—Palpitations—Topiramate—epilepsy syndrome	3.12e-05	9.27e-05	CcSEcCtD
Alitretinoin—Loss of consciousness—Topiramate—epilepsy syndrome	3.1e-05	9.22e-05	CcSEcCtD
Alitretinoin—Insomnia—Gabapentin—epilepsy syndrome	3.1e-05	9.2e-05	CcSEcCtD
Alitretinoin—Nausea—Lamotrigine—epilepsy syndrome	3.09e-05	9.17e-05	CcSEcCtD
Alitretinoin—Cough—Topiramate—epilepsy syndrome	3.08e-05	9.15e-05	CcSEcCtD
Alitretinoin—Feeling abnormal—Pregabalin—epilepsy syndrome	3.08e-05	9.14e-05	CcSEcCtD
Alitretinoin—Paraesthesia—Gabapentin—epilepsy syndrome	3.08e-05	9.13e-05	CcSEcCtD
Alitretinoin—Convulsion—Topiramate—epilepsy syndrome	3.06e-05	9.09e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.05e-05	9.07e-05	CcSEcCtD
Alitretinoin—Dyspnoea—Gabapentin—epilepsy syndrome	3.05e-05	9.07e-05	CcSEcCtD
Alitretinoin—Hypertension—Topiramate—epilepsy syndrome	3.05e-05	9.05e-05	CcSEcCtD
Alitretinoin—Somnolence—Gabapentin—epilepsy syndrome	3.04e-05	9.04e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.04e-05	9.04e-05	CcSEcCtD
Alitretinoin—Dyspepsia—Gabapentin—epilepsy syndrome	3.01e-05	8.95e-05	CcSEcCtD
Alitretinoin—Chest pain—Topiramate—epilepsy syndrome	3.01e-05	8.93e-05	CcSEcCtD
Alitretinoin—Myalgia—Topiramate—epilepsy syndrome	3.01e-05	8.93e-05	CcSEcCtD
Alitretinoin—Arthralgia—Topiramate—epilepsy syndrome	3.01e-05	8.93e-05	CcSEcCtD
Alitretinoin—Anxiety—Topiramate—epilepsy syndrome	3e-05	8.9e-05	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.98e-05	8.87e-05	CcSEcCtD
Alitretinoin—Decreased appetite—Gabapentin—epilepsy syndrome	2.98e-05	8.84e-05	CcSEcCtD
Alitretinoin—Discomfort—Topiramate—epilepsy syndrome	2.97e-05	8.82e-05	CcSEcCtD
Alitretinoin—Urticaria—Pregabalin—epilepsy syndrome	2.97e-05	8.81e-05	CcSEcCtD
Alitretinoin—Asthenia—Valproic Acid—epilepsy syndrome	2.96e-05	8.8e-05	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.96e-05	8.78e-05	CcSEcCtD
Alitretinoin—Fatigue—Gabapentin—epilepsy syndrome	2.95e-05	8.77e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Pregabalin—epilepsy syndrome	2.95e-05	8.77e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Pregabalin—epilepsy syndrome	2.95e-05	8.77e-05	CcSEcCtD
Alitretinoin—Dry mouth—Topiramate—epilepsy syndrome	2.94e-05	8.73e-05	CcSEcCtD
Alitretinoin—Pain—Gabapentin—epilepsy syndrome	2.93e-05	8.7e-05	CcSEcCtD
Alitretinoin—Constipation—Gabapentin—epilepsy syndrome	2.93e-05	8.7e-05	CcSEcCtD
Alitretinoin—Pruritus—Valproic Acid—epilepsy syndrome	2.92e-05	8.68e-05	CcSEcCtD
Alitretinoin—Confusional state—Topiramate—epilepsy syndrome	2.91e-05	8.63e-05	CcSEcCtD
Alitretinoin—Oedema—Topiramate—epilepsy syndrome	2.88e-05	8.56e-05	CcSEcCtD
Alitretinoin—Infection—Topiramate—epilepsy syndrome	2.86e-05	8.5e-05	CcSEcCtD
Alitretinoin—Shock—Topiramate—epilepsy syndrome	2.83e-05	8.42e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Valproic Acid—epilepsy syndrome	2.83e-05	8.4e-05	CcSEcCtD
Alitretinoin—Nervous system disorder—Topiramate—epilepsy syndrome	2.83e-05	8.39e-05	CcSEcCtD
Alitretinoin—Feeling abnormal—Gabapentin—epilepsy syndrome	2.82e-05	8.38e-05	CcSEcCtD
Alitretinoin—Thrombocytopenia—Topiramate—epilepsy syndrome	2.82e-05	8.38e-05	CcSEcCtD
Alitretinoin—Tachycardia—Topiramate—epilepsy syndrome	2.81e-05	8.35e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.8e-05	8.32e-05	CcSEcCtD
Alitretinoin—Skin disorder—Topiramate—epilepsy syndrome	2.8e-05	8.31e-05	CcSEcCtD
Alitretinoin—Hyperhidrosis—Topiramate—epilepsy syndrome	2.79e-05	8.27e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Pregabalin—epilepsy syndrome	2.75e-05	8.17e-05	CcSEcCtD
Alitretinoin—Anorexia—Topiramate—epilepsy syndrome	2.75e-05	8.16e-05	CcSEcCtD
Alitretinoin—Dizziness—Valproic Acid—epilepsy syndrome	2.73e-05	8.11e-05	CcSEcCtD
Alitretinoin—Urticaria—Gabapentin—epilepsy syndrome	2.72e-05	8.08e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Gabapentin—epilepsy syndrome	2.71e-05	8.04e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Gabapentin—epilepsy syndrome	2.71e-05	8.04e-05	CcSEcCtD
Alitretinoin—Hypotension—Topiramate—epilepsy syndrome	2.69e-05	8e-05	CcSEcCtD
Alitretinoin—Asthenia—Pregabalin—epilepsy syndrome	2.68e-05	7.96e-05	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	2.65e-05	0.000228	CbGpPWpGaD
Alitretinoin—Pruritus—Pregabalin—epilepsy syndrome	2.64e-05	7.85e-05	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—NR3C1—epilepsy syndrome	2.64e-05	0.000227	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.63e-05	0.000226	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—YWHAZ—epilepsy syndrome	2.63e-05	0.000226	CbGpPWpGaD
Alitretinoin—Vomiting—Valproic Acid—epilepsy syndrome	2.63e-05	7.8e-05	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.63e-05	7.8e-05	CcSEcCtD
Alitretinoin—RARA—Gene Expression—H2AFX—epilepsy syndrome	2.61e-05	0.000225	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—H2AFX—epilepsy syndrome	2.61e-05	0.000225	CbGpPWpGaD
Alitretinoin—Insomnia—Topiramate—epilepsy syndrome	2.61e-05	7.74e-05	CcSEcCtD
Alitretinoin—Rash—Valproic Acid—epilepsy syndrome	2.6e-05	7.74e-05	CcSEcCtD
Alitretinoin—Dermatitis—Valproic Acid—epilepsy syndrome	2.6e-05	7.73e-05	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	2.6e-05	0.000223	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	2.6e-05	0.000223	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.59e-05	0.000223	CbGpPWpGaD
Alitretinoin—Headache—Valproic Acid—epilepsy syndrome	2.59e-05	7.69e-05	CcSEcCtD
Alitretinoin—RARB—Gene Expression—NR3C1—epilepsy syndrome	2.59e-05	0.000222	CbGpPWpGaD
Alitretinoin—Paraesthesia—Topiramate—epilepsy syndrome	2.59e-05	7.68e-05	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	2.59e-05	0.000222	CbGpPWpGaD
Alitretinoin—Dyspnoea—Topiramate—epilepsy syndrome	2.57e-05	7.63e-05	CcSEcCtD
Alitretinoin—Somnolence—Topiramate—epilepsy syndrome	2.56e-05	7.61e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Pregabalin—epilepsy syndrome	2.56e-05	7.59e-05	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—POMC—epilepsy syndrome	2.54e-05	0.000218	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—POMC—epilepsy syndrome	2.54e-05	0.000218	CbGpPWpGaD
Alitretinoin—Dyspepsia—Topiramate—epilepsy syndrome	2.54e-05	7.53e-05	CcSEcCtD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.53e-05	0.000218	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Gabapentin—epilepsy syndrome	2.52e-05	7.49e-05	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—YWHAZ—epilepsy syndrome	2.52e-05	0.000217	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—YWHAZ—epilepsy syndrome	2.52e-05	0.000217	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TXNRD1—epilepsy syndrome	2.51e-05	0.000215	CbGpPWpGaD
Alitretinoin—Decreased appetite—Topiramate—epilepsy syndrome	2.5e-05	7.44e-05	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.49e-05	0.000214	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.49e-05	7.39e-05	CcSEcCtD
Alitretinoin—Fatigue—Topiramate—epilepsy syndrome	2.48e-05	7.38e-05	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	2.48e-05	0.000213	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NR3C1—epilepsy syndrome	2.48e-05	0.000213	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NR3C1—epilepsy syndrome	2.48e-05	0.000213	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	2.48e-05	0.000213	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	2.48e-05	0.000213	CbGpPWpGaD
Alitretinoin—Dizziness—Pregabalin—epilepsy syndrome	2.47e-05	7.34e-05	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.47e-05	0.000212	CbGpPWpGaD
Alitretinoin—Constipation—Topiramate—epilepsy syndrome	2.46e-05	7.32e-05	CcSEcCtD
Alitretinoin—Pain—Topiramate—epilepsy syndrome	2.46e-05	7.32e-05	CcSEcCtD
Alitretinoin—Asthenia—Gabapentin—epilepsy syndrome	2.46e-05	7.3e-05	CcSEcCtD
Alitretinoin—Nausea—Valproic Acid—epilepsy syndrome	2.45e-05	7.29e-05	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	2.45e-05	0.00021	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	2.44e-05	0.000209	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AQP1—epilepsy syndrome	2.43e-05	0.000209	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	2.43e-05	0.000209	CbGpPWpGaD
Alitretinoin—Pruritus—Gabapentin—epilepsy syndrome	2.42e-05	7.2e-05	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.39e-05	0.000205	CbGpPWpGaD
Alitretinoin—Vomiting—Pregabalin—epilepsy syndrome	2.37e-05	7.05e-05	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	2.37e-05	0.000204	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	2.37e-05	0.000204	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	2.37e-05	0.000204	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	2.37e-05	0.000204	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Topiramate—epilepsy syndrome	2.37e-05	7.05e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.36e-05	7e-05	CcSEcCtD
Alitretinoin—Rash—Pregabalin—epilepsy syndrome	2.35e-05	6.99e-05	CcSEcCtD
Alitretinoin—Dermatitis—Pregabalin—epilepsy syndrome	2.35e-05	6.99e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Gabapentin—epilepsy syndrome	2.34e-05	6.96e-05	CcSEcCtD
Alitretinoin—Headache—Pregabalin—epilepsy syndrome	2.34e-05	6.95e-05	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.34e-05	0.000201	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—epilepsy syndrome	2.31e-05	0.000199	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—epilepsy syndrome	2.31e-05	0.000199	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.3e-05	0.000198	CbGpPWpGaD
Alitretinoin—Urticaria—Topiramate—epilepsy syndrome	2.29e-05	6.8e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Topiramate—epilepsy syndrome	2.28e-05	6.77e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Topiramate—epilepsy syndrome	2.28e-05	6.77e-05	CcSEcCtD
Alitretinoin—Dizziness—Gabapentin—epilepsy syndrome	2.26e-05	6.73e-05	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—EIF2S1—epilepsy syndrome	2.25e-05	0.000193	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA13—epilepsy syndrome	2.23e-05	0.000192	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.22e-05	0.000191	CbGpPWpGaD
Alitretinoin—Nausea—Pregabalin—epilepsy syndrome	2.22e-05	6.59e-05	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	2.22e-05	0.00019	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	2.22e-05	0.00019	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.21e-05	0.00019	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KDR—epilepsy syndrome	2.2e-05	0.000189	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—KCNJ11—epilepsy syndrome	2.2e-05	0.000189	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CHRM3—epilepsy syndrome	2.2e-05	0.000189	CbGpPWpGaD
Alitretinoin—Vomiting—Gabapentin—epilepsy syndrome	2.18e-05	6.47e-05	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—HSPB1—epilepsy syndrome	2.17e-05	0.000186	CbGpPWpGaD
Alitretinoin—Rash—Gabapentin—epilepsy syndrome	2.16e-05	6.41e-05	CcSEcCtD
Alitretinoin—Dermatitis—Gabapentin—epilepsy syndrome	2.16e-05	6.41e-05	CcSEcCtD
Alitretinoin—Headache—Gabapentin—epilepsy syndrome	2.15e-05	6.37e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Topiramate—epilepsy syndrome	2.12e-05	6.31e-05	CcSEcCtD
Alitretinoin—ABCB1—Metabolism—PDXK—epilepsy syndrome	2.12e-05	0.000182	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CERS1—epilepsy syndrome	2.12e-05	0.000182	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	2.12e-05	0.000182	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FAR1—epilepsy syndrome	2.12e-05	0.000182	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADK—epilepsy syndrome	2.12e-05	0.000182	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GLUD1—epilepsy syndrome	2.12e-05	0.000182	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6ST—epilepsy syndrome	2.11e-05	0.000182	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.11e-05	0.000181	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	2.1e-05	0.000181	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.08e-05	0.000178	CbGpPWpGaD
Alitretinoin—Asthenia—Topiramate—epilepsy syndrome	2.07e-05	6.14e-05	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.05e-05	0.000176	CbGpPWpGaD
Alitretinoin—Pruritus—Topiramate—epilepsy syndrome	2.04e-05	6.05e-05	CcSEcCtD
Alitretinoin—Nausea—Gabapentin—epilepsy syndrome	2.03e-05	6.04e-05	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—PTGS2—epilepsy syndrome	2.02e-05	0.000174	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—epilepsy syndrome	2.02e-05	0.000174	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.02e-05	0.000174	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.01e-05	0.000173	CbGpPWpGaD
Alitretinoin—Diarrhoea—Topiramate—epilepsy syndrome	1.97e-05	5.86e-05	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.94e-05	0.000167	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.94e-05	0.000166	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.94e-05	0.000166	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.94e-05	0.000166	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.94e-05	0.000166	CbGpPWpGaD
Alitretinoin—Dizziness—Topiramate—epilepsy syndrome	1.91e-05	5.66e-05	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.88e-05	0.000161	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.88e-05	0.000161	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.85e-05	0.000159	CbGpPWpGaD
Alitretinoin—Vomiting—Topiramate—epilepsy syndrome	1.83e-05	5.44e-05	CcSEcCtD
Alitretinoin—Rash—Topiramate—epilepsy syndrome	1.82e-05	5.4e-05	CcSEcCtD
Alitretinoin—Dermatitis—Topiramate—epilepsy syndrome	1.82e-05	5.39e-05	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—JUNB—epilepsy syndrome	1.81e-05	0.000156	CbGpPWpGaD
Alitretinoin—Headache—Topiramate—epilepsy syndrome	1.81e-05	5.36e-05	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.8e-05	0.000155	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.8e-05	0.000155	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA4—epilepsy syndrome	1.8e-05	0.000155	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.8e-05	0.000155	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.79e-05	0.000154	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCG2—epilepsy syndrome	1.79e-05	0.000154	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2C19—epilepsy syndrome	1.75e-05	0.00015	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP11A1—epilepsy syndrome	1.74e-05	0.000149	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.72e-05	0.000148	CbGpPWpGaD
Alitretinoin—Nausea—Topiramate—epilepsy syndrome	1.71e-05	5.08e-05	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—FGF2—epilepsy syndrome	1.71e-05	0.000147	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—COX3—epilepsy syndrome	1.69e-05	0.000146	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.69e-05	0.000145	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.69e-05	0.000145	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.69e-05	0.000145	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.69e-05	0.000145	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.69e-05	0.000145	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.69e-05	0.000145	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.67e-05	0.000144	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.66e-05	0.000142	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.61e-05	0.000139	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.6e-05	0.000138	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.6e-05	0.000138	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.6e-05	0.000138	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.6e-05	0.000138	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.6e-05	0.000138	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RELA—epilepsy syndrome	1.58e-05	0.000136	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.57e-05	0.000135	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2D6—epilepsy syndrome	1.57e-05	0.000135	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.55e-05	0.000133	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.55e-05	0.000133	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.55e-05	0.000133	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.55e-05	0.000133	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.55e-05	0.000133	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.53e-05	0.000132	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.49e-05	0.000129	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ADRA2A—epilepsy syndrome	1.49e-05	0.000128	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.49e-05	0.000128	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—BCHE—epilepsy syndrome	1.49e-05	0.000128	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.47e-05	0.000126	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.47e-05	0.000126	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.47e-05	0.000126	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.46e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SIRT1—epilepsy syndrome	1.46e-05	0.000125	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.44e-05	0.000124	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.44e-05	0.000124	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—VDR—epilepsy syndrome	1.44e-05	0.000123	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.43e-05	0.000123	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC2A1—epilepsy syndrome	1.42e-05	0.000122	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.41e-05	0.000121	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PLCB1—epilepsy syndrome	1.4e-05	0.000121	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TH—epilepsy syndrome	1.4e-05	0.00012	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.39e-05	0.000119	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.38e-05	0.000118	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.36e-05	0.000117	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.36e-05	0.000117	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—H2AFX—epilepsy syndrome	1.36e-05	0.000117	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.35e-05	0.000116	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—epilepsy syndrome	1.35e-05	0.000116	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.32e-05	0.000113	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—YWHAZ—epilepsy syndrome	1.31e-05	0.000113	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NR3C1—epilepsy syndrome	1.29e-05	0.000111	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.28e-05	0.00011	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.28e-05	0.00011	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.28e-05	0.00011	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.28e-05	0.00011	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.28e-05	0.00011	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.28e-05	0.00011	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.27e-05	0.000109	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.25e-05	0.000108	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.25e-05	0.000107	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—SRC—epilepsy syndrome	1.25e-05	0.000107	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.24e-05	0.000107	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.22e-05	0.000105	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.22e-05	0.000105	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.22e-05	0.000105	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—epilepsy syndrome	1.21e-05	0.000104	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.21e-05	0.000104	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.19e-05	0.000102	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.17e-05	0.000101	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.17e-05	0.000101	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.17e-05	0.000101	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMOX1—epilepsy syndrome	1.17e-05	0.0001	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.16e-05	9.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.16e-05	9.97e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAT—epilepsy syndrome	1.15e-05	9.89e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.14e-05	9.76e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.13e-05	9.7e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCB1—epilepsy syndrome	1.12e-05	9.62e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.11e-05	9.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.09e-05	9.38e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.09e-05	9.36e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.09e-05	9.36e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.07e-05	9.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.06e-05	9.15e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.06e-05	9.15e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GPX1—epilepsy syndrome	1.04e-05	8.95e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—epilepsy syndrome	1.04e-05	8.94e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.04e-05	8.91e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.02e-05	8.8e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—epilepsy syndrome	1.02e-05	8.74e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—epilepsy syndrome	1.02e-05	8.74e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1e-05	8.61e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	9.96e-06	8.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	9.95e-06	8.55e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	9.86e-06	8.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AQP1—epilepsy syndrome	9.72e-06	8.36e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NT5E—epilepsy syndrome	9.71e-06	8.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALAD—epilepsy syndrome	9.71e-06	8.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	9.26e-06	7.96e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	9.26e-06	7.96e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AGT—epilepsy syndrome	9.12e-06	7.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	9.06e-06	7.79e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOE—epilepsy syndrome	8.94e-06	7.69e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	8.89e-06	7.64e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADSL—epilepsy syndrome	8.88e-06	7.63e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—epilepsy syndrome	8.83e-06	7.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	8.79e-06	7.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	8.79e-06	7.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GLUL—epilepsy syndrome	8.71e-06	7.49e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	8.55e-06	7.35e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—epilepsy syndrome	8.08e-06	6.95e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	7.99e-06	6.87e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—epilepsy syndrome	7.92e-06	6.81e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AQP1—epilepsy syndrome	7.76e-06	6.67e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—epilepsy syndrome	7.74e-06	6.65e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—POMC—epilepsy syndrome	7.68e-06	6.6e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—epilepsy syndrome	7.6e-06	6.53e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—epilepsy syndrome	7.6e-06	6.53e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.45e-06	6.41e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	7.17e-06	6.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	7.02e-06	6.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	7.02e-06	6.03e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—epilepsy syndrome	7e-06	6.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	6.98e-06	6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	6.94e-06	5.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.62e-06	5.69e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.54e-06	5.62e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.4e-06	5.51e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	6.26e-06	5.39e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—epilepsy syndrome	6.13e-06	5.27e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.97e-06	5.14e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	5.96e-06	5.13e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BCHE—epilepsy syndrome	5.94e-06	5.11e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	5.72e-06	4.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.67e-06	4.87e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	5.6e-06	4.82e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TH—epilepsy syndrome	5.58e-06	4.8e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	5.58e-06	4.79e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	5.54e-06	4.76e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.5e-06	4.73e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.02e-06	4.31e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	5e-06	4.3e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	4.76e-06	4.09e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BCHE—epilepsy syndrome	4.74e-06	4.08e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.66e-06	4.01e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAT—epilepsy syndrome	4.6e-06	3.95e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	4.52e-06	3.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	4.47e-06	3.85e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TH—epilepsy syndrome	4.46e-06	3.83e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.39e-06	3.77e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.16e-06	3.57e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—epilepsy syndrome	3.96e-06	3.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.72e-06	3.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.67e-06	3.16e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AGT—epilepsy syndrome	3.65e-06	3.13e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOE—epilepsy syndrome	3.57e-06	3.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.57e-06	3.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.32e-06	2.85e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—epilepsy syndrome	3.08e-06	2.65e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—POMC—epilepsy syndrome	3.07e-06	2.64e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.91e-06	2.5e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.85e-06	2.45e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—epilepsy syndrome	2.8e-06	2.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.45e-06	2.11e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.45e-06	2.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.23e-06	1.92e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.95e-06	1.68e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.23e-06	1.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—epilepsy syndrome	9.82e-07	8.44e-06	CbGpPWpGaD
